Literature DB >> 17549187

The use of botulinum neurotoxin type A (Botox) for headaches: a case review.

Mia Oliver1, Joanna MacDonald, Moez Rajwani.   

Abstract

Chiropractic care is a common treatment sought by patients with headaches. As some patients may not benefit from this care, chiropractors must be aware of alternative management options. Botox has more recently become a common treatment for headaches. A case of a 45-year-old female with chronic headaches and neck pain is presented. After lengthy trials of chiropractic manipulation, trigger point therapy, and acupuncture, the patient was treated with Botox-A. She experienced pain relief following the initial treatment that lasted up to 3-4 months and has since undergone subsequent trials of Botox with the same results. No side effects were experienced. As more health care practitioners are recommending Botox, the need for a better understanding of the evidence and criteria for referral for Botox treatment is required. As such, chiropractors should consider this alternative approach to managing headaches when chiropractic management is unsuccessful.

Entities:  

Year:  2006        PMID: 17549187      PMCID: PMC1840000     

Source DB:  PubMed          Journal:  J Can Chiropr Assoc        ISSN: 0008-3194


  22 in total

Review 1.  Noncosmetic uses of botulinum toxin.

Authors:  Boris Bentsianov; Craig Zalvan; Andrew Blitzer
Journal:  Clin Dermatol       Date:  2004 Jan-Feb       Impact factor: 3.541

2.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

Review 3.  Procedures for administering botulinum toxin type A for migraine and tension-type headache.

Authors:  Andrew M Blumenfeld; William Binder; Stephen D Silberstein; Andrew Blitzer
Journal:  Headache       Date:  2003-09       Impact factor: 5.887

4.  Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial.

Authors:  W J Schmitt; E Slowey; N Fravi; S Weber; J M Burgunder
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

5.  Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Authors:  Stephen D Silberstein; Stuart R Stark; Sylvia M Lucas; Suzanne N Christie; Ronald E Degryse; Catherine C Turkel
Journal:  Mayo Clin Proc       Date:  2005-09       Impact factor: 7.616

6.  Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Authors:  Ninan T Mathew; Benjamin M Frishberg; Marek Gawel; Rozalina Dimitrova; John Gibson; Catherine Turkel
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

Review 7.  Treatment of headache with botulinum toxin A--a review according to evidence-based medicine criteria.

Authors:  S Evers; A Rahmann; J Vollmer-Haase; I-W Husstedt
Journal:  Cephalalgia       Date:  2002-11       Impact factor: 6.292

8.  Features of medication overuse headache following overuse of different acute headache drugs.

Authors:  V Limmroth; Z Katsarava; G Fritsche; S Przywara; H-C Diener
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

Review 9.  Possible mechanisms for the effects of botulinum toxin on pain.

Authors:  Joseph C Arezzo
Journal:  Clin J Pain       Date:  2002 Nov-Dec       Impact factor: 3.442

Review 10.  Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.

Authors:  Mark F Lew
Journal:  Clin J Pain       Date:  2002 Nov-Dec       Impact factor: 3.442

View more
  2 in total

Review 1.  Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States.

Authors:  Shilpadevi Patil; Olga Willett; Terin Thompkins; Robert Hermann; Sathish Ramanathan; Elyse M Cornett; Charles J Fox; Alan David Kaye
Journal:  Curr Pain Headache Rep       Date:  2016-03

2.  Botulinum Toxin Injection-Site Selection for a Smooth Shoulder Line: An Anatomical Study.

Authors:  Je Hun Lee; Key Youn Lee; Ji Young Kim; Woo Hyeon Son; Ji Heun Jeong; Young Gil Jeong; Seongoh Kwon; Seung Ho Han
Journal:  Biomed Res Int       Date:  2017-01-26       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.